Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Guardian Pharmacy Services, Inc. Class A Common Stock (NY:GRDN)

40.62 +0.62 (+1.55%)
Delayed Quote Updated: 12:07 PM EST, Nov 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Guardian Pharmacy Services, Inc. Class A Common Stock

News headline image
Guardian Pharmacy Services (GRDN) Q2 2026 Earnings Call Transcript ↗
Adjusted EBITDA surged 19% despite IRA pricing headwinds and fuel cost pressures. 
Via The Motley Fool
Topics Earnings Economy
News headline image
Guardian Pharmacy Services Q2 Earnings Call Highlights ↗
Guardian Pharmacy Services (NYSE:GRDN) reported second-quarter revenue growth of 2% year over year to $351.2 million, while adjusted EBITDA increased 19% to $29.7 million, as the company said it... 
Via MarketBeat
Topics Earnings Economy
Guardian Pharmacy Services (NYSE:GRDN) Beats Q2 EPS, Raises Full-Year Guidance ↗
Via Chartmill
News headline image
Guardian Pharmacy Services Q1 Earnings Call Highlights ↗
Guardian Pharmacy Services (NYSE:GRDN) reported what executives described as a solid first quarter of 2026, with management saying the company successfully navigated the initial implementation of the... 
Via MarketBeat
Topics Earnings Economy
Guardian Pharmacy Services (NYSE:GRDN) Q1 2026 Earnings Beat and Guidance Hike Fail to Spark Stock Rally ↗
Via Chartmill
Topics Earnings
Guardian Pharmacy Services (NYSE:GRDN) Reports Strong Q4 Beat and Raises 2026 Profit Outlook ↗
Via Chartmill
News headline image
Guardian (GRDN) Q1 2026 Earnings Transcript ↗
Guardian (GRDN) Q1 2026 Earnings Transcript 
Via The Motley Fool
News headline image
Guardian Pharmacy (GRDN) Earnings Transcript ↗
Guardian Pharmacy (GRDN) Earnings Transcript 
Via The Motley Fool
News headline image
Guardian Pharmacy Services (NYSE:GRDN) Passes Key Minervini Trend Template and Growth Momentum Screen ↗
GRDN stock passes the Minervini Trend Template with strong technicals and high-growth momentum, showing powerful earnings growth and analyst upgrades. 
Via Chartmill
News headline image
Earnings Scheduled For November 10, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 12, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For November 12, 2024 ↗
 
Via Benzinga
News headline image
Guardian Pharmacy Services (NYSE:GRDN) Identified as a High-Growth Momentum Stock by Minervini Strategy ↗
Guardian Pharmacy Services (GRDN) aligns with Mark Minervini's momentum strategy, showing strong earnings growth of 139% and a bullish technical trend above key moving averages. 
Via Chartmill
News headline image
5 Small-Cap Stocks With Impressive Growth and Upside Potential ↗
Via MarketBeat
News headline image
Guardian Pharmacy Stock Pops on Q3 Strength and Upbeat Forecast ↗
Via MarketBeat
News headline image
Why Guardian Pharmacy Services Stock Was on a Tear Tuesday ↗
The relatively new healthcare stock was attracting positive attention for a good quarterly earnings report. 
Via The Motley Fool
News headline image
Deal Dispatch: TV Stations For Sale, This Buyer Wants Seconds On Pasta ↗
Byron Allen dials out, Salesforce logs in. Here are the various deal announcements of the past week plus bankruptcy updates. 
Via Benzinga
Topics Bankruptcy
News headline image
Earnings Scheduled For August 11, 2025 ↗
 
Via Benzinga
News headline image
Guardian Pharmacy Strengthens US Footprint With New Seattle-Area Acquisition ↗
Guardian Pharmacy Services acquires Mercury Pharmacy Services in Washington, expanding its presence in the Pacific Northwest and meeting growing demand for LTC support. 
Via Benzinga
News headline image
S&P 500 Moves Lower; Lowe's Earnings Top Views ↗
 
Via Benzinga
Topics Stocks
News headline image
Earnings Scheduled For March 26, 2025 ↗
 
Via Benzinga
News headline image
Zscaler, TransMedics Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Stellantis, PG&E And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Aecom Reports Q4 Results, Joins Incyte And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Newly Listed Guardian Pharmacy Is Well Positioned In Highly Fragmented Market, Analyst Initiates With Buy Rating ↗
Truist initiates coverage of Guardian Pharmacy, projecting a $22 price target due to strong growth in the $24.8 billion institutional pharmacy market. 
Via Benzinga
News headline image
This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
 
Via Benzinga
News headline image
Self-Driving Startup Pony.ai Files For U.S. IPO ↗
Self-driving startup Pony.ai of China filed for an IPO in the U.S. this week. Meanwhile, four companies -- Springview Holdings, Oriental Rise Holdings, PTL Limited, and Samfine Creation Holdings Group... 
Via Talk Markets
Topics Initial Public Offering
News headline image
Obesity Drug Developer BioAge Makes Nasdaq Debut ↗
Shares of BioAge Labs opened for trading this week, with the company planning to use the proceeds of its initial public offering to take its lead obesity drug further into clinical trials. 
Via Talk Markets
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.